Global In-Vitro Diagnostics Market Report 2023: Market Segments, Size, Trend and Market Projections for Upcoming Years

According a report published by Infinium Global Research the global in-vitro diagnostics market was worth USD 62.5 billion in 2016 and it is projected to reach USD 92.7 billion in 2023, expanding at a CAGR of 6.0% between 2017 and 2023. Technological advancements and innovations to drive the growth in this market in the near future, owing to high level of competition among the key players in this industry.

Get Free Sample Pages of this Report: https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/807

Demand for Personalized Medicine Is On the Rise

The global market for in-vitro diagnostic is driven by factors such as innovations, and need for personalized medicine. In several health conditions such as diabetes, HIV among others the personalized medicine allows the clinicians to reduce the occurrence of side effects of medicine on the patients. Clinicians also can manage the treatments through real time and customized approaches. Moreover in the oncology therapeutic area the demand for personalized medicine as it encompasses individualized treatment and patient management through real time diagnostic and treatments. As a result several companies operating in the in-vitro diagnostic market are focusing more on personalized medicine. Thus, the growth in demand personalization of the medicine is likely to augment the market size of in-vitro diagnostics market over the forecast period. 

Get 15% Discount on this Report: https://www.infiniumglobalresearch.com/Reports/requestdiscount/807

North America is estimated to command the largest share of the market

North America accounted for the largest market for in-vitro diagnostic over the past couple years. The Europe accounted for the second largest market share after North America.  Presence of medical reimbursement facilities and technological advancements in the region are considered to be the key factors driving the dominance of North America in global in-vitro diagnostic market. The Asia-Pacific region is anticipated to grow at the highest CAGR over the forecast period. The growth of Asia pacific in-vitro diagnostic market is considered to be driven by rapidly increasing per capita healthcare expenditure and higher focus on research in in-vitro diagnostic by key players across the region. Developing economies in Asia pacific such as India and China are likely to bring more opportunities for major player over the forecast period.

In-Vitro Diagnostics Instruments Market by Product
• Immunochemistry
• Clinical Microbiology
• POCT
• SMBG
• Tissue Diagnostics
• Molecular Diagnostics
• Hematology
• Hemostasis

Global In-Vitro Diagnostics Instruments Market by End User
• Hospitals and diagnostic laboratories
• Homecare
• Academic and Research Institutes

Browse the Detailed TOC of the Report on: https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_in_vitro_diagnostics_instruments_market  

Companies Profiled Covered in this Report

The companies covered in the report include Abbott Laboratories, Inc., Siemens AG, Sysmex Corporation, Becton, Dickinson and Company, Ortho-Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc.,  Danaher Corporation, Thermo Fisher Scientific, Inc., Qiagen N.V., Johnson & Johnson, Roche Diagnostics, Diasorin S.P.A., and  Biomérieux SA.

About Us:

Infinium Global Research and Consulting Solutions is started with a single motto of being business partner of first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you.

Contact Us:

Infinium Global Research
Goyal Shinde Park, Bhau Patil Road,
Bopodi, Pune-411 020.
U.S. + Canada Toll Free: 1-800-638-0796
Email: sales@infiniumglobalresearch.com

This release was published on openPR.